Search results for "Mach"

showing 10 items of 3360 documents

A deeper look into natural sciences with physics-based and data-driven measures

2021

Summary With the development of machine learning in recent years, it is possible to glean much more information from an experimental data set to study matter. In this perspective, we discuss some state-of-the-art data-driven tools to analyze latent effects in data and explain their applicability in natural science, focusing on two recently introduced, physics-motivated computationally cheap tools—latent entropy and latent dimension. We exemplify their capabilities by applying them on several examples in the natural sciences and show that they reveal so far unobserved features such as, for example, a gradient in a magnetic measurement and a latent network of glymphatic channels from the mous…

0301 basic medicineDynamical systems theory02 engineering and technologyMachine learningcomputer.software_genreData-drivenSet (abstract data type)03 medical and health sciencesArtificial IntelligenceEntropy (information theory)Dimension (data warehouse)lcsh:ScienceApplied PhysicsMultidisciplinarybusiness.industryPhysicsPerspective (graphical)MagnetismExperimental dataPhysik (inkl. Astronomie)021001 nanoscience & nanotechnology030104 developmental biologyPerspectiveComputer Sciencelcsh:QRelaxation (approximation)Artificial intelligence0210 nano-technologybusinesscomputeriScience
researchProduct

In Situ Representations and Access Consciousness in Neural Blackboard or Workspace Architectures

2018

Phenomenal theories of consciousness assert that consciousness is based on specific neural correlates in the brain, which can be separated from all cognitive functions we can perform. If so, the search for robot consciousness seems to be doomed. By contrast, theories of functional or access consciousness assert that consciousness can be studied only with forms of cognitive access, given by cognitive processes. Consequently, consciousness and cognitive access cannot be fully dissociated. Here, the global features of cognitive access of consciousness are discussed based on neural blackboard or (global) workspace architectures, combined with content addressable or "in situ" representations as …

0301 basic medicineElectromagnetic theories of consciousnessComputer scienceProcess (engineering)lcsh:Mechanical engineering and machineryin situ representationsmedia_common.quotation_subjectWorkspacelcsh:QA75.5-76.9503 medical and health sciences0302 clinical medicineArtificial Intelligencelcsh:TJ1-1570global workspacemedia_commonRobotics and AICognitive scienceaccess consciousnessNeural correlates of consciousnessneural blackboard architecturesCognitionconnection pathsBlackboard (design pattern)Computer Science Applications030104 developmental biologyCovertPerspectiverobotslcsh:Electronic computers. Computer scienceConsciousness030217 neurology & neurosurgeryFrontiers in Robotics and AI
researchProduct

Chip Formation and Control

2008

This chapter provides comprehensive engineering knowledge and modelling techniques applied in description of chip formation in the cutting zone and its separation from the bulk material, flow, and final breaking. Possible classification systems, including different chip shapes and physical mechanisms of their formation, are specified. The mechanisms of brittle fracture-based and shear-type chips are characterized in terms of plastic deformation and fracture mechanics. The models of the shear angle using different mechanical approaches are discussed. In addition, representative examples of FEM simulations of different types of chips for turning and milling operations are presented. Formulas …

0301 basic medicineEngineeringMaterials sciencebusiness.industryChip formationFlow (psychology)Mechanical engineeringFracture mechanicsStructural engineeringManufacturing systemsChip03 medical and health sciences030104 developmental biology0302 clinical medicineMachiningEmbedded system030220 oncology & carcinogenesisShear anglebusinessBrittle fractureComputingMethodologies_COMPUTERGRAPHICS
researchProduct

Association of Long Non-Coding RNA Polymorphisms with Gastric Cancer and Atrophic Gastritis

2020

Long non-coding RNAs (lncRNA) play an important role in the carcinogenesis of various tumours, including gastric cancer. This study aimed to assess the associations of lncRNA ANRIL, H19, MALAT1, MEG3, HOTAIR single-nucleotide polymorphisms (SNPs) with gastric cancer and atrophic gastritis. SNPs were analyzed in 613 gastric cancer patients, 118 patients with atrophic gastritis and 476 controls from three tertiary centers in Germany, Lithuania and Latvia. Genomic DNA was extracted from peripheral blood leukocytes. SNPs were genotyped by the real-time polymerase chain reaction. Results showed that carriers of MALAT1 rs3200401 CT genotype had the significantly higher odds of atrophic gastritis …

0301 basic medicineGastritis AtrophicMalemedicine.medical_specialtylcsh:QH426-470GenotypeAtrophic gastritisSingle-nucleotide polymorphismmedicine.disease_causeGastroenterologyPolymorphism Single NucleotideArticleTertiary Care Centers03 medical and health sciences0302 clinical medicineGene FrequencyStomach NeoplasmsInternal medicineGermanyatrophic gastritisGenotypeGeneticsmedicineOdds RatioHumansGenetic Predisposition to DiseaseRNA NeoplasmGenetics (clinical)AllelesAgedMALAT1long non-coding RNAbusiness.industrylong non-coding RNA ; single-nucleotide polymorphism ; gastric cancer ; atrophic gastritisgastric cancerCancerHOTAIRMiddle Agedsingle-nucleotide polymorphismmedicine.diseaseLong non-coding RNAlcsh:Genetics030104 developmental biology030220 oncology & carcinogenesisFemaleRNA Long NoncodingCarcinogenesisbusinessGenes
researchProduct

Use of deep learning methods to translate drug-induced gene expression changes from rat to human primary hepatocytes

2020

In clinical trials, animal and cell line models are often used to evaluate the potential toxic effects of a novel compound or candidate drug before progressing to human trials. However, relating the results of animal and in vitro model exposures to relevant clinical outcomes in the human in vivo system still proves challenging, relying on often putative orthologs. In recent years, multiple studies have demonstrated that the repeated dose rodent bioassay, the current gold standard in the field, lacks sufficient sensitivity and specificity in predicting toxic effects of pharmaceuticals in humans. In this study, we evaluate the potential of deep learning techniques to translate the pattern of …

0301 basic medicineGene ExpressionGene Expression Regulation/drug effectsPathology and Laboratory MedicineConvolutional neural networkTOXICITYMachine LearningVoeding Metabolisme en GenomicaTime Measurement0302 clinical medicineGene expressionMedicine and Health SciencesMeasurementClinical Trials as TopicMultidisciplinaryArtificial neural networkPharmaceuticsQRMetabolism and GenomicsTOXICOGENOMICS030220 oncology & carcinogenesisMetabolisme en GenomicaMedicineEngineering and TechnologyNutrition Metabolism and GenomicsHepatocytes/drug effectsAlgorithmsResearch ArticleComputer and Information SciencesClinical Trials as Topic/statistics & numerical dataNeural NetworksGenetic ToxicologyTOXICOLOGYSciencePredictive ToxicologyComputational biologyBiologyComputer03 medical and health sciencesDose Prediction MethodsDeep LearningVoedingArtificial IntelligenceIn vivoGeneticsLife ScienceAnimalsHumansGeneNutritionbusiness.industryDeep learningBiology and Life SciencesGold standard (test)REPRESENTATIONSRats030104 developmental biologyGene Expression RegulationHepatocytesArtificial intelligenceNeural Networks ComputerToxicogenomicsbusinessNeuroscience
researchProduct

Boosting Action Observation and Motor Imagery to Promote Plasticity and Learning

2018

Neural Plasticity, 2018

0301 basic medicineImagery PsychotherapyBoosting (machine learning)Article SubjectComputer scienceMovementMachine learningcomputer.software_genrestimulationlcsh:RC321-57103 medical and health sciences0302 clinical medicineMotor imageryHumansLearninglcsh:Neurosciences. Biological psychiatry. NeuropsychiatryComputingMilieux_MISCELLANEOUSNeuronal Plasticitybusiness.industryBraincortexEditorial030104 developmental biologyNeurologyAction observationImagination[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Neurology (clinical)Artificial intelligencebusinesscomputer030217 neurology & neurosurgery
researchProduct

Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer.

2019

The aim of this manuscript is to discuss the viewpoint of the European Organisation for Research and Treatment of Cancer (EORTC) Gastric Cancer Taskforce and Japan Clinical Oncology Group (JCOG) Gastric Cancer Study Group on the current challenges in the multidisciplinary management of stage II-III gastric and gastro-oesophageal junction (GEJ) cancer. We seek to outline how these challenges are addressed in current trials of both groups. Key elements of future trials of EORTC and JCOG in this indication are described, and a joint vision on how multidisciplinary research of gastric and GEJ cancer patients should be organised is outlined. ispartof: EUROPEAN JOURNAL OF CANCER vol:124 pages:67-…

0301 basic medicineMaleCancer ResearchEsophageal NeoplasmsADJUVANT CHEMOTHERAPY0302 clinical medicineEUROPEAN ORGANIZATIONMultidisciplinary approachGastricPerioperativeStage (cooking)AdjuvantClinical OncologyMISMATCH REPAIR DEFICIENCYdigestive oral and skin physiologyGastro oesophageal junctionOPEN-LABELPrognosisJCOGhumanitiesEORTCOncology030220 oncology & carcinogenesisCLINICAL-RESEARCHFemaleImmunotherapyEsophagogastric JunctionRANDOMIZED PHASE-IILife Sciences & Biomedicinemedicine.medical_specialtyStage ii03 medical and health sciencesStomach NeoplasmsmedicineChemotherapyHumansNeoplasm StagingScience & Technologybusiness.industryPERIOPERATIVE CHEMOTHERAPYGeneral surgeryCancerADENOCARCINOMAPLUS OXALIPLATINmedicine.diseaseSurvival Analysisdigestive system diseases030104 developmental biologyNeoplasm stagingbusinessTRIAL DESIGNEuropean journal of cancer (Oxford, England : 1990)
researchProduct

A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer

2018

Introduction IMAB362 (Zolbetuximab) is a chimeric monoclonal antibody that binds to Claudin-18.2, a target antigen specific to cancer cells. In vitro, IMAB362 mediates cell death through antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity; thus, IMAB362 may serve as a potent, targeted immunotherapeutic agent. Methods This first-in-human phase I study enroled adult patients (N = 15) with advanced gastric or gastro-oesophageal junction cancer into five sequential single dose-escalation cohorts (33, 100, 300, 600, and 1000 mg/m2) following a 3 + 3 design. Safety/tolerability, including determination of maximum tolerated dose and recommended phase II dose, were the pr…

0301 basic medicineMaleCancer Researchmedicine.medical_specialtyTime FactorsEsophageal NeoplasmsMaximum Tolerated Dosemedicine.medical_treatmentMedizinGastroenterologyAntibodies Monoclonal/administration & dosage03 medical and health sciences0302 clinical medicineAntineoplastic Agents ImmunologicalPharmacokineticsAntineoplastic Agents Immunological/administration & dosageStomach NeoplasmsInternal medicineGermanymedicineHumansDrug Dosage CalculationsAdverse effectInfusions IntravenousAgedbusiness.industryCancerAntibodies MonoclonalEsophagogastric Junction/drug effectsImmunotherapyMiddle Agedmedicine.diseaseLatviaddc:030104 developmental biologyTreatment OutcomeOncologyTolerabilityResponse Evaluation Criteria in Solid Tumors030220 oncology & carcinogenesisToxicityDisease ProgressionFemaleStomach Neoplasms/drug therapyEsophagogastric JunctionEsophageal Neoplasms/drug therapybusinessProgressive disease
researchProduct

Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro…

2018

BACKGROUND: There currently are no internationally recognised treatment guidelines for patients with advanced gastric cancer/gastro-oesophageal junction cancer (GC/GEJC) in whom two prior lines of therapy have failed. The randomised, phase III JAVELIN Gastric 300 trial compared avelumab versus physician's choice of chemotherapy as third-line therapy in patients with advanced GC/GEJC. PATIENTS AND METHODS: Patients with unresectable, recurrent, locally advanced, or metastatic GC/GEJC were recruited at 147 sites globally. All patients were randomised to receive either avelumab 10 mg/kg by intravenous infusion every 2 weeks or physician's choice of chemotherapy (paclitaxel 80 mg/m2 on days 1, …

0301 basic medicineMaleEsophageal Neoplasmsmedicine.medical_treatmentchemotherapyGastroenterologyChoice Behaviorlaw.invention0302 clinical medicineRandomized controlled triallawAntineoplastic Combined Chemotherapy ProtocolsClinical endpointMedicinePractice Patterns Physicians'Aged 80 and overHazard ratioAntibodies MonoclonalHematologyMiddle AgedPrognosisChemotherapy regimenAdenocarcinoma MucinousSurvival RateOncology030220 oncology & carcinogenesisFemaleImmunotherapyEsophagogastric Junctionmedicine.drugPD-L1Adultmedicine.medical_specialtyAdolescentPaclitaxelAdenocarcinomaAntibodies Monoclonal HumanizedIrinotecanDecision Support Techniquesgastro-oesophageal junction cancer03 medical and health sciencesYoung AdultStomach NeoplasmsInternal medicineGastrointestinal TumorsHumansddc:610Survival rateAgedChemotherapybusiness.industrygastric cancerInternational AgenciesOriginal Articlesphase IIICarcinoma PapillaryClinical trialIrinotecanEditor's Choice030104 developmental biologyavelumabNeoplasm Recurrence LocalbusinessCarcinoma Signet Ring CellBiomarkersFollow-Up Studies
researchProduct

Predicting the spatial abundance of Ixodes ricinus ticks in southern Scandinavia using environmental and climatic data

2019

AbstractRecently, focus on tick-borne diseases has increased as ticks and their pathogens have become widespread and represent a health problem in Europe. Understanding the epidemiology of tick-borne infections requires the ability to predict and map tick abundance. We measured Ixodes ricinus abundance at 159 sites in southern Scandinavia from August-September, 2016. We used field data and environmental variables to develop predictive abundance models using machine learning algorithms, and also tested these models on 2017 data. Larva and nymph abundance models had relatively high predictive power (normalized RMSE from 0.65–0.69, R2 from 0.52–0.58) whereas adult tick models performed poorly …

0301 basic medicineMaleIxodes ricinus030231 tropical medicinelcsh:MedicineTickForestsScandinavian and Nordic CountriesPopulation densityModels BiologicalArticle03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingAbundance (ecology)Machine learningparasitic diseasesVDP::Matematikk og Naturvitenskap: 400::Basale biofag: 470AnimalsEcosystemNymphlcsh:ScienceWeatherEcosystemEcological epidemiologyPopulation DensityMultidisciplinarybiologyIxodesEcologylcsh:RVegetationbiology.organism_classification030104 developmental biologyLarva/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingInfectious diseasesIxodeslcsh:QFemaleEnvironmental Monitoring
researchProduct